Seven UK Health Tech Start-Ups Win Up to £70,000 in Incubator Support
Seven health technology start-ups have been chosen for funding of up to £70,000 each through the DTC Health incubation programme. Led by the Science and Technology Facilities Council (STFC), the initiative aims to help bring early-stage medical innovations to market more quickly. The selected companies will have access to AI prototyping facilities, alongside support on intellectual property, commercial planning and business strategy.
The latest cohort covers a wide range of clinical problems. HMA Technologies is developing a wearable robotic arm to help stroke survivors carry out physical rehabilitation exercises at home. Asika is building artificial intelligence agents to automate routine administrative work in clinical and hospital settings, an area where staff time is often taken up by paperwork.
Two of the companies are working on diagnostics that pair specialised hardware with artificial intelligence. CCI Photonics is constructing a platform that uses infrared light and artificial intelligence to detect infections at the point of care. Beyond Blood is engineering a portable device that combines microfluidics with artificial intelligence to deliver rapid blood analysis in outpatient settings.
Eyetech Innovations is manufacturing a portable tool that measures eye movement, giving clinicians additional information when they assess neurological and ophthalmic conditions. InformiX Pharma is applying advanced 3D X-ray imaging to analyse the structure of pharmaceutical compounds and support targeted drug design. UKind XR is designing trauma-informed virtual reality and artificial intelligence tools for patients who are waiting for mental health therapy.
Leadership at the STFC has said the incubation support is meant to translate laboratory research into clinical solutions that can scale. The initiative sits within wider national efforts to support digital transformation across the healthcare sector. Because the funding is described as up to £70,000, the final value of each package may differ between companies.
The announcement coincides with several other developments in UK health technology. A £2.4 million UK Research and Innovation (UKRI) Future Leaders Fellowship has been awarded to establish a "living lab" at Manchester University NHS Foundation Trust. The four-year project includes a trial of 800 patients, which will assess how wearable monitors affect people undergoing major thoracic and abdominal surgery. Trials of this size allow researchers to compare outcomes across a large group of patients treated in a single hospital setting.
Separately, recruitment has opened for the sixth cohort of the NHS Fellowship in Clinical AI. The 12-month programme provides salary support for clinicians for two days each week. Fellows use that time to evaluate and implement safe artificial intelligence models within active hospital workflows. The scheme gives practising clinicians protected time to work on such projects, which would otherwise compete with their routine duties.
The annual Health Tech Awards have also highlighted emerging technologies across the sector. The awards showcased digital tools designed to improve the running of clinical services and the outcomes patients experience.
For the seven start-ups in the DTC Health cohort, the immediate benefit is access to prototyping resources and specialist advice at an early stage of development. Several of the products, including the rehabilitation arm, the infection detection platform and the blood analysis device, are aimed at settings outside the hospital ward, such as patients' homes and outpatient clinics. Whether they reach routine clinical use will depend on further development, testing and regulatory approval, none of which the incubation funding is described as covering.
